Latest Leadership News

Bapcor Limited has revised its first-half FY26 guidance to a statutory net loss, citing weaker trade segment performance and one-off costs, while maintaining a cautiously optimistic full-year outlook supported by cost savings and leadership changes.

Arcadia Minerals announces key leadership departures and a strategic pivot towards gold and critical minerals acquisitions, alongside planned drilling at its promising TVC Project in Namibia.

Emeco Group reveals a robust FY25 with $785 million revenue, nearly half from its expanding maintenance services, underpinned by advanced asset management technology and a strategic push into new sectors.

Whitebark Energy has appointed Nik Sykiotis as CEO, positioning the company to advance its strategic focus on natural hydrogen, helium, and hydrocarbons. Sykiotis’s operational expertise is expected to steer Whitebark through its next growth phase.

Eastern Gas Corporation Limited, a Pure One subsidiary, has lodged a prospectus to raise $5.5 million to advance exploration and development of its Queensland gas assets, aiming for a standalone ASX listing.

Antares Metals Limited (ASX, AM5) has announced a significant acquisition of gold and base metals assets in Western Australia, positioning itself for a maiden drilling campaign in early 2026.

Antares Metals (ASX – AM5) announces the acquisition of full interests in two promising Western Australian gold and copper-zinc projects, backed by a $2 million capital raise to fund exploration and drilling in early 2026.

Memphasys is intensifying its direct sales efforts for the Felix™ sperm-selection device across key Middle East IVF clinics, positioning for rapid market activation upon CE Mark approval expected early 2026.

Miramar Resources has secured A$1 million through a share placement to fund a targeted RC drilling campaign at its high-potential Gidji JV gold project, while appointing a new director to strengthen its board.

American Rare Earths has appointed mining veteran Mark Wall as CEO to lead its transition from exploration to production, focusing on advancing its flagship Halleck Creek project and expanding its U.S. market presence.

Imugene Limited has received positive feedback from the FDA, aligning key requirements to progress its azer-cel therapy into a pivotal clinical trial, underscoring its growing promise in blood cancer treatment.

Sparc Hydrogen has appointed Alana Barlow as its inaugural CEO, marking a strategic move to accelerate commercialisation of its innovative photocatalytic water splitting technology for green hydrogen.